Supervivencia de pacientes con fibrosis pulmonar idiopática diagnosticados por biopsia quirúrgica de pulmón: experiencia del Instituto Nacional del Tórax

par Salinas,Mauricio, Florenzano,Matías, Sabbagh,Eduardo, Meneses,Manuel, Fernández,Cristina, Jalilie,Alfredo, Rodríguez,Juan Carlos, Cavada,Gabriel, Undurraga,Álvaro
Publié 2014

Utilidad de la crio-tecnología para uso diagnóstico y terapéutico en neumología intervencionista: crio-biopsia pulmonar transbronquial y crioterapia

par Montufar,Franco, Moral,Lucrecia Del, Labarca,Gonzalo, Folch,Erik, Majid,Adnan, Fernandez-Bussy,Sebastian
Publié 2018

Neumonía intersticial inducida por bloqueo androgénico máximo como tratamiento de cáncer de próstata avanzado: Report of one case

par Molina Mancero,Guillermo, Picón,Xavier, Di Tullio,Fernando, Ernst,Glenda, Dezanzo,Pablo, Salvado,Alejandro, Chertcoff,Julio F
Publié 2016

Enfermedades pulmonares intersticiales. Una perspectiva actual

par SALINAS,MAURICIO, FLORENZANO,MATÍAS, WOLFF,VERÓNICA, RODRÍGUEZ,JUAN CARLOS, VALENZUELA,HUGO, FERNÁNDEZ,CRISTINA, UNDURRAGA,ÁLVARO
Publié 2019

Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial

par Gian Marco Manzetti, Karishma Hosein, Matthew J. Cecchini, Keith Kwan, Mohamed Abdelrazek, Maurizio Zompatori, Paola Rogliani, Marco Mura
Publié 2021

Spermidine-mediated poly(lactic-co-glycolic acid) nanoparticles containing fluorofenidone for the treatment of idiopathic pulmonary fibrosis

par Tang J, Li JM, Li G, Zhang HT, Wang L, Li D, Ding JS
Publié 2017

The Effect of Cardiovascular Medications on Disease-Related Outcomes in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

par Wan-Tong Zhang, Xu-Jie Wang, Chun-Miao Xue, Xin-Yu Ji, Lin Pan, Wei-Liang Weng, Wei-Liang Weng, Qiu-Yan Li, Qiu-Yan Li, Guo-Dong Hua, Bao-Chen Zhu
Publié 2021

Effects of Systemic Enzyme Supplements on Symptoms and Quality of Life in Patients with Pulmonary Fibrosis—A Pilot Study

par Neha Shah
Publié 2021

Interstitial lung abnormalities – current knowledge and future directions

par Gisli Thor Axelsson, Gunnar Gudmundsson
Publié 2021

Variability in Global Prevalence of Interstitial Lung Disease

par Bhavika Kaul, Vincent Cottin, Vincent Cottin, Harold R. Collard, Claudia Valenzuela
Publié 2021

Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial

par Diana Badenes-Bonet, Pilar Cejudo, Anna Rodó-Pin, Clara Martín-Ontiyuelo, Roberto Chalela, Jose Antonio Rodríguez-Portal, Rosa Vázquez-Sánchez, Joaquim Gea, Xavier Duran, Oswaldo Antonio Caguana, Diego Agustín Rodriguez-Chiaradia, Eva Balcells
Publié 2021

Editorial: From Development to Senescence, Bridging the Gap in Lung Fibrosis

par Jason J. Gokey
Publié 2021

Quantification of Cancer-Developing Idiopathic Pulmonary Fibrosis Using Whole-Lung Texture Analysis of HRCT Images

par Chia-Hao Liang, Yung-Chi Liu, Yung-Liang Wan, Chun-Ho Yun, Wen-Jui Wu, Rafael López-González, Wei-Ming Huang
Publié 2021

Deleterious Role of Th9 Cells in Pulmonary Fibrosis

par Kui Miao Deng, Xiang Sheng Yang, Qun Luo, Yi Xin She, Qing Yang Yu, Xiao Xiao Tang
Publié 2021

Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis

par Henrik Jessen, Nils Hoyer, Thomas S. Prior, Peder Frederiksen, Sarah R. Rønnow, Morten A. Karsdal, Diana J. Leeming, Elisabeth Bendstrup, Jannie M. B. Sand, Saher B. Shaker
Publié 2021

CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis

par Yupeng Li, Shibin Chen, Xincheng Li, Xue Wang, Huiwen Li, Shangwei Ning, Hong Chen
Publié 2021

Effect of home-based pulmonary rehabilitation on functional capacity in people with idiopathic pulmonary fibrosis—a systematic review protocol

par Revati Amin, K. Vaishali, G. Arun Maiya, Aswini Kumar Mohapatra, Uday Narayan Yadav, Shradha S. Parsekar
Publié 2021

The Potentially Therapeutic Role of EPAC in Curbing the Process of Idiopathic Pulmonary Fibrosis via Differential Cellular Pathways

par Cao X, Li Y, Shi J, Tang H
Publié 2021

The effects of collagen-rich extracellular matrix on the intracellular delivery of glycol chitosan nanoparticles in human lung fibroblasts

par Yhee JY, Yoon HY, Kim H, Jeon S, Hergert P, Im J, Panyam J, Kim K, Nho RS
Publié 2017

Evaluation of microRNA expression in a sheep model for lung fibrosis

par Udari Eshani Perera, Habtamu B. Derseh, Sasika N. V. Dewage, Andrew Stent, Rukmali Wijayarathna, Kenneth J. Snibson
Publié 2021